| Literature DB >> 29264466 |
E Michael Lewiecki1, Rachelle Rochelle2, Matthew F Bouchonville3, David H Chafey4, Thomas P Olenginski5, Sanjeev Arora3.
Abstract
Osteoporosis is a common condition with serious consequences because of fractures. Despite availability of treatments to reduce fracture risk, there is a large osteoporosis treatment gap that has reached crisis proportions. There are too few specialists to provide services for patients who need them. Bone Health Extension for Community Health Care Outcomes (TeleECHO) is a strategy using real-time ongoing videoconferencing technology to mentor health care professionals in rural and underserved communities to achieve an advanced level of knowledge for the care of patients with skeletal diseases. Over the first 21 months of weekly Bone Health TeleECHO programs, there were 263 registered health care professionals in the United States and several other countries, with 221 attending at least 1 online clinic and typically 35 to 40 attendees at each session at the end of the reported period. Assessment of self-confidence in 20 domains of osteoporosis care showed substantial improvement with the ECHO intervention (P = 0.005). Bone Health TeleECHO can contribute to mitigating the crisis in osteoporosis care by leveraging scarce resources, providing motivated practitioners with skills to provide better skeletal health care, closer to home, with greater convenience, and lower cost than referral to a specialty center. Bone Health TeleECHO can be replicated in any location worldwide to reach anyone with Internet access, allowing access in local time zones and languages. The ECHO model of learning can be applied to other aspects of bone care, including the education of fracture liaison service coordinators, residents and fellows, and physicians with an interest in rare bone diseases.Entities:
Keywords: ECHO Act; Project ECHO; osteoporosis; telehealth; telemedicine; treatment gap
Year: 2017 PMID: 29264466 PMCID: PMC5695652 DOI: 10.1210/js.2017-00361
Source DB: PubMed Journal: J Endocr Soc ISSN: 2472-1972
Bone Health TeleECHO Outcomes Data
| 1 | Identify patients who would benefit from pharmacological treatment to reduce fracture risk | 4.40 | 5.90 | 1.50 | 0.97 |
| 2 | Evaluate patients for secondary causes of osteoporosis | 4.10 | 5.70 | 1.60 | 1.51 |
| 3 | Assess patients for risk of falling | 4.90 | 5.70 | 0.80 | 0.92 |
| 4 | Understand potential side effects of pharmacological medications used for treatment of osteoporosis | 4.00 | 5.60 | 1.60 | 1.26 |
| 5 | Educate my clinic staff about the management of osteoporosis patients | 4.30 | 5.70 | 1.40 | 1.26 |
| 6 | Understand the balance of benefits and risks with osteoporosis medications | 4.30 | 5.70 | 1.40 | 1.07 |
| 7 | Effectively communicate the balance of benefits and risks with osteoporosis medications | 4.40 | 5.70 | 1.30 | 1.34 |
| 8 | Serve as a consultant in my clinic and in my community for osteoporosis care | 4.40 | 6.00 | 1.60 | 1.26 |
| 9 | Understand the pathophysiology of osteoporosis | 4.60 | 5.90 | 1.30 | 1.25 |
| 10 | Use the WHO FRAX to help with clinical decisions | 3.90 | 5.30 | 1.40 | 1.43 |
| 11 | Use the National Osteoporosis Foundation treatment guidelines | 4.20 | 5.40 | 1.20 | 1.14 |
| 12 | Distinguish good quality from poor quality acquisition, analysis, and reporting of bone density testing by DXA | 4.00 | 5.60 | 1.60 | 1.78 |
| 13 | Use DXA effectively in managing patients with osteoporosis | 4.20 | 5.50 | 1.30 | 1.57 |
| 14 | Individualize osteoporosis treatment decisions | 4.30 | 5.80 | 1.50 | 1.35 |
| 15 | Identify, evaluate, and treat patients with suboptimal response to osteoporosis treatment | 3.80 | 5.40 | 1.60 | 1.17 |
| 16 | Explain the benefits of secondary fracture prevention with a hospital-based FLS | 3.90 | 4.90 | 1.00 | 1.41 |
| 17 | Use the WHO criteria for classifying patients as having osteopenia, osteoporosis, or severe osteoporosis | 4.80 | 6.10 | 1.30 | 1.49 |
| 18 | Recommend interventions to reduce fall risk | 5.00 | 6.00 | 1.00 | 1.25 |
| 19 | Discuss the benefits and risks of nonpharmacological therapy for osteoporosis | 4.90 | 6.00 | 1.10 | 1.29 |
| 20 | Diagnose and treat men with osteoporosis | 3.90 | 5.40 | 1.50 | 1.51 |
After 10 months of weekly online clinics (October 2015 through July 2016), learners were asked to rate confidence in skills for 20 domains of osteoporosis care before and after the ECHO intervention. Results are for those who participated in at least 10 clinics and had direct patient care responsibilities (n = 10). Overall rating was 4.32 before ECHO and 5.67 after ECHO (P = 0.005 for difference). Rating scale: 0 = not applicable; 1 = none or no skill; 2 = vague knowledge, skills, or competence; 3 = slight knowledge, sills, or competence; 4 = average among my peers; 5 = competent; 6 = very competent; 7 = expert, teach others.
Abbreviations: DXA, dual-energy X-ray absorptiometry; FRAX, fracture risk assessment tool; WHO, World Health Organization.
Figure 1.United States map of Bone Health TeleECHO “hub and spoke” network (21 months’ data). The ECHO hub in Albuquerque links to faculty to learners and learners to other learners through collaborative, ongoing, real-time case-based medical education. Participants were located in 34 states and the District of Columbia. Participants in other countries are not shown on this map.
Figure 2.Bone Health TeleECHO outcomes. Learners with direct patient care responsibilities who attended more than 10 TeleECHO clinics (n = 10) were evaluated for self-confidence in managing osteoporosis patients in 20 different domains of care. There was a very large effect size [13] (P = 0.005) after the ECHO intervention compared with before the intervention.